UPDATED May 23, 2023
Companies that are potentially undervalued based on future cash flows and market ratios.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JPHJerusalem Pharmaceuticals | US$4.00 | 0% | 25.0% | US$72.0m | n/a | PE9.8x | n/a | 3.8% | Pharmaceuticals & Biotech |